These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8173955)

  • 1. Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.
    Blin J; Ray CA; Piercey MF; Bartko JJ; Mouradian MM; Chase TN
    Brain Res; 1994 Jan; 635(1-2):196-202. PubMed ID: 8173955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography.
    Blin J; Piercey MF; Giuffra ME; Mouradian MM; Chase TN
    J Neurol Sci; 1994 May; 123(1-2):44-51. PubMed ID: 8064320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat.
    Ray CA; Blin J; Chase TN; Piercey MF
    Neuropharmacology; 1992 Nov; 31(11):1193-9. PubMed ID: 1475026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of cholinergic and glutamatergic neuronal systems in the functional activation of cerebral blood flow response: a PET study in unanesthetized monkeys.
    Tsukada H; Kakiuchi T; Shizuno H; Nishiyama S
    Brain Res; 1998 Jun; 796(1-2):82-90. PubMed ID: 9689457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzepine.
    Shurtleff D; Raslear TG; Genovese RF; Simmons L
    Physiol Behav; 1992 Feb; 51(2):381-90. PubMed ID: 1557449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces.
    Piercey MF; Vogelsang GD; Franklin SR; Tang AH
    Brain Res; 1987 Oct; 424(1):1-9. PubMed ID: 3690290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine.
    Grenhoff J; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):395-8. PubMed ID: 1436125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique central cholinergic deficit in the spontaneously hypertensive rat: physostigmine reveals a bradycardia associated with sensory stimulation.
    Taylor BK; Holloway D; Printz MP
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1081-90. PubMed ID: 8138921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain.
    Alberch J; Carman-Krzan M; Fabrazzo M; Wise BC
    Brain Res; 1991 Mar; 542(2):233-40. PubMed ID: 1851454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat.
    Bassant MH; Jazat F; Lamour Y
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):855-64. PubMed ID: 8360291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physostigmine reversal of scopolamine-induced hypofrontality.
    Prohovnik I; Arnold SE; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):220-8. PubMed ID: 9040502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic regulation of female sexual behavior in rats demonstrated by manipulation of endogenous acetylcholine.
    Clemens LG; Barr P; Dohanich GP
    Physiol Behav; 1989 Feb; 45(2):437-42. PubMed ID: 2756032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic response to tacrine (THA) and physostigmine in the aged rat brain.
    Bassant MH; Jazat-Poindessous F; Lamour Y
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):1093-102. PubMed ID: 7593342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine reversal of tremor produced by low doses of physostigmine in rats: evidence for a cholinergic mechanism.
    Stanford JA; Fowler SC
    Neurosci Lett; 1997 Apr; 225(3):157-60. PubMed ID: 9147394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.
    Addy NA; Nunes EJ; Wickham RJ
    Behav Brain Res; 2015 Jul; 288():54-62. PubMed ID: 25865152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single administration of scopolamine, physostigmine and their combination on biogenic amine levels in rat brain.
    Hrbek J; Rypka M; Hrbek J
    Acta Univ Palacki Olomuc Fac Med; 1989; 121():271-5. PubMed ID: 2533807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cerebral blood flow response to somatosensory stimulation through the cholinergic system: a positron emission tomography study in unanesthetized monkeys.
    Tsukada H; Kakiuchi T; Ando I; Shizuno H; Nakanishi S; Ouchi Y
    Brain Res; 1997 Feb; 749(1):10-7. PubMed ID: 9070622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physostigmine results in an increased decrement in brain glucose consumption in Alzheimer's disease.
    Blin J; Ivanoiu A; De Volder A; Michel C; Bol A; Verellen C; Seron X; Duprez T; Laterre EC
    Psychopharmacology (Berl); 1998 Apr; 136(3):256-63. PubMed ID: 9566811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood glucose and brain function: interactions with CNS cholinergic systems.
    Stone WS; Cottrill KL; Walker DL; Gold PE
    Behav Neural Biol; 1988 Nov; 50(3):325-34. PubMed ID: 3202815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.